News

In “The Psychedelic Dante,” an article in the February 6, 2015 issue of The American Conservative, writer Rod Dreher discovers parallels between the psychedelic experience and Dante’s Divine Comedy. Dreher begins by noting significant results in current psychedelic science with references to Heffter-supported research by Roland...

An article by Heffter researcher Matthew Johnson and his colleagues is bringing international media attention to the promise of psychedelic therapy. “Psychedelic Medicine: A Reemerging Therapeutic Paradigm,” published in the Canadian Medical Association Journal, reviews the use of psychedelics for treating serious disorders including anxiety, addiction,...

Blogger Andrew Penn continues his series on psychedelics with an entry about the challenges that face mental health professionals who study and work with these substances. In “Psychedelics: What to Tell Patients Today,” Penn discusses the problem of explaining psychedelic therapy to patients who may be...

A new documentary titled Dying to Know chronicles the friendship of two twentieth century icons, Timothy Leary and Richard Alpert, aka Ram Dass. Their research at Harvard fifty years ago inspired the psychedelic movement of the 1960s. Producer/Director Gay Dillingham worked with Heffter on a...

The Heffter Research Institute is sponsoring another study on psilocybin and mystical experience. Researchers Stephen Ross and Anthony Bossis at the New York University School of Medicine are studying the effects of psilocybin on individuals who lead religious congregations or spiritual communities. The link below is...

The Purdue Exponent, the daily student newspaper of Purdue University, has a feature article on the work of David Nichols, the co-founder and President of the Heffter Research Institute. Staff writer Danielle Wilkinson covers Dr. Nichols’ research on the psychedelic chemicals MDMA (“Ecstasy”) and LSD. “’We...